OARSI–OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials

OBJECTIVE: Total joint replacement has been proposed as an endpoint in disease modifying osteoarthritis drug (DMOAD) randomized clinical trials (RCTs); however, disparities have generated concerns regarding this outcome. A combined Osteoarthritis Research Society International (OARSI)/Outcome Measur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Osteoarthritis Cartilage
Main Authors: Manno, R.L., Bingham, C.O., Paternotte, S., Gossec, L., Halhol, H., Giacovell, G., Rovati, L., Mazzuca, S.A., Clegg, D.O., Shi, H., Tajana Messi, E., Lanzarotti, A., Dougados, M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4375956/
https://ncbi.nlm.nih.gov/pubmed/22178465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2011.11.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados